Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2013;2(4):477-89.
doi: 10.3233/JHD-130076.

Regional atrophy associated with cognitive and motor function in prodromal Huntington disease

Elizabeth H Aylward  1 , Deborah L Harrington  2 , James A Mills  3 , Peggy C Nopoulos  3 , Christopher A Ross  4 , Jeffrey D Long  3 , Dawei Liu  3 , Holly K Westervelt  5 , Jane S Paulsen  6 ; PREDICT-HD Investigators and Coordinators of the Huntington Study Group
Collaborators, Affiliations
Observational Study

Regional atrophy associated with cognitive and motor function in prodromal Huntington disease

Elizabeth H Aylward et al. J Huntingtons Dis. 2013.

Abstract

Background: Neuroimaging studies suggest that volumetric MRI measures of specific brain structures may serve as excellent biomarkers in future clinical trials of Huntington disease (HD).

Objective: Demonstration of the clinical significance of these measures is an important step in determining their appropriateness as potential outcome measures.

Methods: Measures of gray- and white-matter lobular volumes and subcortical volumes (caudate, putamen, globus pallidus, thalamus, nucleus accumbens, hippocampus) were obtained from MRI scans of 516 individuals who tested positive for the HD gene expansion, but were not yet exhibiting signs or symptoms severe enough to warrant diagnosis ("pre-HD"). MRI volumes (corrected for intracranial volume) were correlated with cognitive, motor, psychiatric, and functional measures known to be sensitive to subtle changes in pre-HD.

Results: Caudate, putamen, and globus pallidus volumes consistently correlated with cognitive and motor, but not psychiatric or functional measures in pre-HD. Volumes of white matter, nucleus accumbens, and thalamus, but not cortical gray matter, also correlated with some of the motor and cognitive measures.

Conclusions: Results of regression analyses suggest that volumes of basal ganglia structures contributed more highly to the prediction of most motor and cognitive variables than volumes of other brain regions. These results support the use of volumetric measures, especially of the basal ganglia, as outcome measures in future clinical trials in pre-HD. Results may also assist investigators in selecting the most appropriate measures for treatment trials that target specific clinical features or regions of neuropathology.

Keywords: Huntington disease; cognitive; magnetic resonance imaging; motor; psychiatric.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest: The authors have no conflict of interest to report.

References

    1. Bechtel N, Scahill RI, Rosas HD, Acharya T, van den Bogaard SJ, Jauffret C, Say MJ, Sturrock A, Johnson H, Onorato CE, Salat DH, Durr A, Leavitt BR, Roos RA, Landwehrmeyer GB, Langbehn DR, Stout JC, Tabrizi SJ, Reilmann R. Tapping linked to function and structure in premanifest and symptomatic Huntington disease. Neurology. 2010;75(24):2150–60. - PMC - PubMed
    1. Ruocco H, Lopes-Cendes I, Li L, Santos-Silva M, Cendes F. Striatal and extrastriatal atrophy in Huntington's disease and its relationship with length of the CAG repeat. Braz J Med Biol Res. 2006;39(8):1129–36. - PubMed
    1. van den Bogaard SJ, Dumas EM, Ferrarini L, Milles J, van Buchem MA, van der Grond J, Roos RA. Shape analysis of subcortical nuclei in Huntington's disease, global versus local atrophy–results from the TRACK-HD study. J Neurol Sci. 2011;307(1-2):60–8. - PubMed
    1. Aylward EH, Brandt J, Codori AM, Mangus RS, Barta PE, Harris GJ. Reduced basal ganglia volume associated with the gene for Huntington's disease in asymptomatic at-risk persons. Neurology. 1994;44(5):823–8. - PubMed
    1. Campodonico JR, Aylward E, Codori A, Young C, Krafft L, Magdalinski M, Ranen N, Slavney PR, Brandt J. When does Huntington's disease begin? J Int Neuropsychol Soc. 1998;4(05):467–73. - PubMed

Publication types